Medical Condition News

RSS
Study could pave way for new treatment strategies for PKU

Study could pave way for new treatment strategies for PKU

Electronic health records could help identify people who have undiagnosed type 2 diabetes

Electronic health records could help identify people who have undiagnosed type 2 diabetes

First two patients treated in multi-center clinical trial for perivascular renal denervation

First two patients treated in multi-center clinical trial for perivascular renal denervation

UAB research reveals heterogonous population of leukemia stem cells

UAB research reveals heterogonous population of leukemia stem cells

Heart attack patients experiencing cardiogenic shock at higher risk of death in first 60 days post-discharge

Heart attack patients experiencing cardiogenic shock at higher risk of death in first 60 days post-discharge

Vascular surgery safer than stenting for older patients with carotid stenosis

Vascular surgery safer than stenting for older patients with carotid stenosis

New briefing paper outlines six UK policy proposals to tackle sugar-related problems

New briefing paper outlines six UK policy proposals to tackle sugar-related problems

Regrowing dopaminergic neurons may lead to new therapy for Parkinson's disease

Regrowing dopaminergic neurons may lead to new therapy for Parkinson's disease

Study finds no beneficial effect of cancer medication on Alzheimer's disease

Study finds no beneficial effect of cancer medication on Alzheimer's disease

Study: Delirium, muscle weakness and other neurological complications of sepsis poorly understood

Study: Delirium, muscle weakness and other neurological complications of sepsis poorly understood

New study to evaluate use of whole umbilical cord blood to accelerate stroke recovery

New study to evaluate use of whole umbilical cord blood to accelerate stroke recovery

One specific microRNA has strong links to autism spectrum disorder, say TSRI scientists

One specific microRNA has strong links to autism spectrum disorder, say TSRI scientists

Amgen announces availability of Kyprolis (carfilzomib) in the UK for treatment of relapsed multiple myeloma

Amgen announces availability of Kyprolis (carfilzomib) in the UK for treatment of relapsed multiple myeloma

NICE issues positive guidance for use of Medtronic insulin therapy systems for managing Type 1 diabetes

NICE issues positive guidance for use of Medtronic insulin therapy systems for managing Type 1 diabetes

First patients dosed in Neurotrope's Bryostatin-1 Phase 2b trial for treatment of advanced Alzheimer’s disease

First patients dosed in Neurotrope's Bryostatin-1 Phase 2b trial for treatment of advanced Alzheimer’s disease

Researchers report first-ever link between noradrenergic neurons and vulnerability to depression

Researchers report first-ever link between noradrenergic neurons and vulnerability to depression

Survey: Some patients with multiple sclerosis not engaging with specialist services

Survey: Some patients with multiple sclerosis not engaging with specialist services

TUM researchers make progress in bringing immunotherapy to fight against cancer, infectious diseases

TUM researchers make progress in bringing immunotherapy to fight against cancer, infectious diseases

Sphere Medical to discuss potential application of Proxima at Symposium Intensivmedizin + Intensivpflege 2016

Sphere Medical to discuss potential application of Proxima at Symposium Intensivmedizin + Intensivpflege 2016

University of Derby hosts Dementia Care conference

University of Derby hosts Dementia Care conference

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.